Integra LifeSciences Announces Approval of Two-for-One Stock Split
December 22 2016 - 8:00AM
Integra LifeSciences Holdings Corporation (NASDAQ:IART) today
announced that its stockholders approved a two-for-one stock split
and an increase from 60 million to 240 million authorized shares of
the Company’s common stock at a special meeting of stockholders
held on Wednesday, December 21, 2016.
Holders of record, as of the close of markets on
December 21, 2016, will be entitled to receive one additional share
of common stock for each share held. The shares are expected
to be distributed on January 3, 2017. The adjusted stock
price is expected to be reflected on the NASDAQ stock market on
January 4, 2017.
About Integra
LifeSciencesIntegra LifeSciences Holdings Corporation, a
world leader in medical technology, is dedicated to limiting
uncertainty for clinicians, so they can concentrate on providing
the best patient care. Integra offers innovative solutions,
including leading plastic and regenerative technologies, in
specialty surgical solutions, orthopedics and tissue technologies.
For more information, please visit www.integralife.com.
Statements made at the upcoming conferences may
be forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Such forward-looking
statements involve risks and uncertainties that could cause actual
results to differ from predicted results. Forward-looking factors
that may be discussed include, but are not limited to, future
financial performance, new product development, governmental
approvals, market potential and resulting sales as well as
potential therapeutic applications, and additional acquisitions.
These risks and uncertainties include market conditions and other
factors beyond the Company's control and the economic, competitive,
governmental, technological and other factors identified under the
heading "Risk Factors" included in item 1A of Integra's Annual
Report on Form 10-K for the year ended December 31, 2015 and
information contained in subsequent filings with the Securities and
Exchange Commission could affect actual results. These
forward-looking statements are made only as the date thereof, and
the Company undertakes no obligation to update or revise the
forward-looking statements, whether as a result of new information,
future events or otherwise.
Contacts:
Integra LifeSciences Holdings Corporation
Investor Relations:
Angela Steinway
(609) 936-2268
angela.steinway@integralife.com
Michael Beaulieu
(609) 750-2827
michael.beaulieu@integralife.com
Integra LifeSciences (NASDAQ:IART)
Historical Stock Chart
From Mar 2024 to Apr 2024
Integra LifeSciences (NASDAQ:IART)
Historical Stock Chart
From Apr 2023 to Apr 2024